Cardiolectus Limited Filleted Accounts Cover
Cardiolectus Limited
Company No. 09324973
Information for Filing with The Registrar
31 October 2023
Cardiolectus Limited Directors Report Registrar
The Directors present their report and the accounts for the year ended 31 October 2023.
Principal activities
The principal activity of the company during the year under review was human health activities.
Directors
The Directors who served at any time during the year were as follows:
C.G. Hanratty
J. Spratt
J.W. Strange
S.J. Walsh
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board
J.W. Strange
Director
09 September 2024
Cardiolectus Limited Balance Sheet Registrar
at
31 October 2023
Company No.
09324973
Notes
2023
2022
£
£
Fixed assets
Investments
3
75,16275,162
75,16275,162
Current assets
Debtors
4
11
Cash at bank and in hand
58763
59764
Creditors: Amount falling due within one year
5
(16,057)
(14,956)
Net current liabilities
(15,998)
(14,192)
Total assets less current liabilities
59,16460,970
Net assets
59,16460,970
Capital and reserves
Called up share capital
152152
Share premium account
7
39,95039,950
Profit and loss account
7
19,06220,868
Total equity
59,16460,970
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
For the year ended 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 09 September 2024 and signed on its behalf by:
J.W. Strange
Director
09 September 2024
Cardiolectus Limited Notes to the Accounts Registrar
for the year ended 31 October 2023
1
General information
Cardiolectus Limited is a private company limited by shares and incorporated in England and Wales.
Its registered number is: 09324973
Its registered office is:
2 Chesterfield Buildings
Westbourne Place
Clifton, Bristol
England
BS8 1RU
The accounts have been prepared in accordance with FRS 102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
2
Employees
2023
2022
Number
Number
The average monthly number of employees (including directors) during the year was:
04
3
Investments
Other investments
Total
£
£
Cost or valuation
At 1 November 2022
75,162
75,162
At 31 October 2023
75,162
75,162
Provisions/Impairment
Net book values
At 31 October 2023
75,162
75,162
At 31 October 2022
75,162
75,162
4
Debtors
2023
2022
£
£
Corporation tax recoverable
11
11
5
Creditors:
amounts falling due within one year
2023
2022
£
£
Other loans
700700
Loans from directors
14,25614,256
Accruals and deferred income
1,101-
16,05714,956
6
Share Capital
152 ordinary shares fully paid ay £1.
7
Reserves
Share premium account - includes any premiums received on issue of share capital. Any transaction costs associated with the issuing of shares are deducted from share premium.
Profit and loss account - includes all current and prior period retained profits and losses.
Cardiolectus Limited0932497331 October 202301 November 2022false09 September 2024BTCSoftware AP Solution 2024 11.1.0611.1.06true093249732022-11-012023-10-31093249732023-10-31093249732022-10-3109324973core:WithinOneYear2023-10-3109324973core:WithinOneYear2022-10-3109324973core:ShareCapital2023-10-3109324973core:ShareCapital2022-10-3109324973core:SharePremium2023-10-3109324973core:SharePremium2022-10-3109324973core:RetainedEarningsAccumulatedLosses2023-10-3109324973core:RetainedEarningsAccumulatedLosses2022-10-3109324973countries:UnitedKingdom2022-11-012023-10-3109324973bus:RegisteredOffice2022-11-012023-10-31093249732021-11-012022-10-3109324973core:CostValuation2022-11-0109324973core:CostValuation2023-10-3109324973core:CostValuationcore:UnlistedNon-exchangeTraded2023-10-3109324973core:SharePremium2022-11-012023-10-3109324973core:RetainedEarningsAccumulatedLosses2022-11-012023-10-31093249732022-11-0109324973bus:SmallEntities2022-11-012023-10-3109324973bus:FullAccounts2022-11-012023-10-3109324973bus:AuditExempt-NoAccountantsReport2022-11-012023-10-3109324973bus:Director32022-11-012023-10-3109324973bus:PrivateLimitedCompanyLtd2022-11-012023-10-31iso4217:GBPxbrli:pure